Since PSMA is also known to be expressed in the neovasculature of hypervascular solid tumors, PSMA-PET/CT has been applied to RCC, demonstrating a potential role in the diagnosis of metastatic RCC patients23. The gene discussed is FOLH1; the disease is renal cell carcinoma.